Depressive DisordersAyahuasca

Harmine stimulates proliferation of human neural progenitors

Harmine markedly increases proliferation of human neural progenitor cells (hNPCs) derived from pluripotent stem cells, enlarging the proliferating pool by 71.5% after four days in vitro. The proliferation was mimicked by the DYRK1A inhibitor INDY but not by the MAO inhibitor pargyline, implicating DYRK1A inhibition as a likely mechanism and potentially explaining harmine’s antidepressant effects.

Authors

  • Dakic, V.
  • De Moraes Maciel, R.
  • Drummond, H.

Published

PeerJ
individual Study

Abstract

Harmine is the β -carboline alkaloid with the highest concentration in the psychotropic plant decoction Ayahuasca. In rodents, classical antidepressants reverse the symptoms of depression by stimulating neuronal proliferation. It has been shown that Ayahuasca presents antidepressant effects in patients with depressive disorder. In the present study, we investigated the effects of harmine in cell cultures containing human neural progenitor cells (hNPCs, 97% nestin-positive) derived from pluripotent stem cells. After 4 days of treatment, the pool of proliferating hNPCs increased by 71.5%. Harmine has been reported as a potent inhibitor of the dual specificity tyrosine-phosphorylation-regulated kinase (DYRK1A), which regulates cell proliferation and brain development. We tested the effect of analogs of harmine, an inhibitor of DYRK1A (INDY), and an irreversible selective inhibitor of monoamine oxidase (MAO) but not DYRK1A (pargyline). INDY but not pargyline induced proliferation of hNPCs similarly to harmine, suggesting that inhibition of DYRK1A is a possible mechanism to explain harmine effects upon the proliferation of hNPCs. Our findings show that harmine enhances proliferation of hNPCs and suggest that inhibition of DYRK1A may explain its effects upon proliferation in vitro and antidepressant effects in vivo .

Available with Blossom Pro

Research Summary of 'Harmine stimulates proliferation of human neural progenitors'

Introduction

Adult human brains retain regions where new neural cells are generated from a pool of neural progenitor cells (hNPCs). Previous animal studies link disrupted adult neurogenesis to depression and show that classical antidepressants can stimulate neural proliferation; however, conventional treatments are slow to act and effective in only around 50% of patients. Beta-carbolines such as harmine, present in the ayahuasca decoction, have been associated with rapid antidepressant-like effects in small human studies and with increased neurogenic markers in rodents, but direct evidence for effects on human neural progenitors is lacking. Dakic and colleagues set out to test whether harmine alters proliferation of human neural progenitor cells derived from pluripotent stem cells and to explore possible mechanisms, focussing on inhibition of the kinase DYRK1A and on monoamine oxidase (MAO) activity. The study therefore examines harmine's effect on the size and phenotype of hNPC pools in vitro and compares harmine with a DYRK1A inhibitor (INDY) and an MAO inhibitor (pargyline) to probe possible molecular mediators.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

  • Study Type
    individual
  • Journal
  • Compound
  • Topic
  • APA Citation

    Dakic, V., Maciel, R. D. M., Drummond, H., Nascimento, J. M., Trindade, P., & Rehen, S. K. (2016). Harmine stimulates proliferation of human neural progenitors. PeerJ, 4, e2727. https://doi.org/10.7717/peerj.2727

References (1)

Papers cited by this study that are also in Blossom

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report

Osório, F. L., Sanches, R. F., Macedo, L. et al. · brazilian Journal of Psychiatry (2015)

420 cited

Cited By (13)

Papers in Blossom that reference this study

Long-term ayahuasca use is associated with preserved global cognitive function and improved memory: a cross-sectional study with ritual users

Fonseca, A. M., Dos Santos, R. G., Santos, F. P. et al. · European Archives of Psychiatry and Clinical Neuroscience (2024)

Effects of psychedelics on neurogenesis: A systematic review of pre-clinical studies

Lima da Cruz, R. V., Leão, R. N., Moulin, T. C. · Biorxiv (2023)

The potential of psychedelics for the treatment of Alzheimer's disease and related dementias

Winkelman, M. J., Szabo, A., Frecska, E. · European Neuropsychopharmacology (2023)

Preliminary evidence of links between ayahuasca use and the corpus callosum

Bouso, J. C., Simonsson, O., Kurth, F. et al. · Frontiers in Psychiatry (2022)

Psychedelic-Inspired Approaches for Treating Neurodegenerative Disorders

Olson, D. E. · Journal of Neurochemistry (2021)

Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial

Galvão-Coelho, N. L., de Almeida, R. N., de Menezes Galvão, A. C. et al. · Frontiers in Psychology (2019)

Therapeutic Potential Ascribed to Ayahuasca by Users in the Czech Republic

Horák, M., Hasíková, L., Verter, N. et al. · Journal of Psychoactive Drugs (2018)

Show all 13 papers
The Use of Salvia divinorum from a Mazatec Perspective

Maqueda, A. E. · Plant Medicines Healing and Psychedelic Science (2018)

Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT

Dakic, V., Nascimento, J. M., Sartore, R. C. et al. · Scientific Reports (2017)

112 cited
The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro

Morales-García, J. A., de la Fuente Revenga, M., Alonso-Gil, S. et al. · Scientific Reports (2017)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.